Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SNNA

Sienna Biopharmaceuticals (SNNA) Stock Price, News & Analysis

Sienna Biopharmaceuticals logo

About Sienna Biopharmaceuticals Stock (NASDAQ:SNNA)

Advanced Chart

Key Stats

Today's Range
$0.11
$0.17
50-Day Range
$0.14
$0.14
52-Week Range
$0.06
$3.80
Volume
13.32 million shs
Average Volume
1.87 million shs
Market Capitalization
$4.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SNNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sienna Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SNNA Stock News Headlines

Think you missed gold’s boom? Think again
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because there's a $15 fund tied directly to gold's surge that's still paying massive income… Up to 64% annually — with payouts every 30 days.
See More Headlines

SNNA Stock Analysis - Frequently Asked Questions

Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) released its quarterly earnings results on Thursday, March, 14th. The company reported ($0.93) EPS for the quarter, missing the consensus estimate of ($0.83) by $0.10.

Sienna Biopharmaceuticals (SNNA) raised $64 million in an initial public offering on Thursday, July 27th 2017. The company issued 4,300,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Cowen and BMO Capital Markets acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sienna Biopharmaceuticals investors own include SCYNEXIS (SCYX), Allena Pharmaceuticals (ALNA), Protalix BioTherapeutics (PLX), Sorrento Therapeutics (SRNE), Viking Therapeutics (VKTX), Motif Bio (MTFB) and Ritter Pharmaceuticals (RTTR).

Company Calendar

Last Earnings
3/14/2019
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SNNA
CIK
1656328
Fax
N/A
Employees
39
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.59)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$73.47 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-177.36%
Return on Assets
-52.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
15.27
Quick Ratio
15.27

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.27 per share
Price / Book
0.11

Miscellaneous

Outstanding Shares
30,908,000
Free Float
N/A
Market Cap
$4.20 million
Optionable
Not Optionable
Beta
2.67
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:SNNA) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners